Further research is needed to determine whether RNF20 indirectly regulates systemic insulin homoeostasis through inter‐organ signalling mechanisms, providing potential new therapeutic targets for treating insulin resistance‐related metabolic disorders. This evidence concerns the gene INS and metabolic disease.